Viewing data from:

CIMETIDINE HYDROCHLORIDE

ANDA

CIMETIDINE HYDROCHLORIDE | A074664 | PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.5989

per ml

Lowest NADAC/Unit

$0.5989

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00121102508CIMETIDINE 300 MG/5 ML SOLN	$0.5989	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$148.01

Highest Price

$148.01

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00121-1025-08CIMETIDINE HCL 300MG/5ML LIQUID,ORAL	$148.01	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

GEDEON RICHTER LTDInactiveCIMETIDINE HYDROCHLORIDE

DMF 97691992

CORDEN PHARMA BERGAMO SPAInactiveCIMETIDINE HYDROCHLORIDE

DMF 115831995

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 26, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 300MG BASE/5ML

0 patents0 exclusivities▴

SOLUTION;ORAL | Approved: Oct 28, 1997

No patent or exclusivity listings for this strength.